Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment in Humans

/PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced patients have been dosed in the world’s first study of a potential antibody treatment…

1. Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment in Humans